ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,179.68
-0.55%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,326.98
-0.03%
Brent Oil
85.415
0.00%
Bitcoin
61,471.77
-0.23%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cellect Biotechnology Ltd (APOP)

  7. Cellect Biotechnology Ltd (APOP) News

Cellect Biotechnology (APOP)

Cellect Biotechnology Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APOP
DateTimeSourceHeadlineSymbolCompany
28/06/202320:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/06/202320:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
12/05/202321:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
09/05/202321:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
09/05/202320:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APOPCellect Biotechnology Ltd
08/05/202322:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
22/03/202310:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
20/03/202310:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
15/03/202318:40Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APOPCellect Biotechnology Ltd
03/03/202321:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
28/02/202311:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/02/202311:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
28/02/202311:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
23/02/202311:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:APOPCellect Biotechnology Ltd
14/02/202319:41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
14/02/202316:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
13/02/202311:10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
09/02/202311:05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:APOPCellect Biotechnology Ltd
03/02/202311:03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202314:48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202314:45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202314:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202314:41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
03/01/202314:38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202217:45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202217:44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
10/11/202216:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
07/11/202219:46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
07/11/202219:45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
28/10/202211:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
 Showing the most relevant articles for your search:NASDAQ:APOP

Your Recent History

LSE
3SUS
-3x Short Ubs
NYSE
EGLE
Eagle Bulk Shipping
BOV
AMAR1
LOJAS MARISA ON
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved